RNAM
Avidity Biosciences
RNAM
RNAM
Delisted
RNAM was delisted on the 26th of February, 2026.
236 hedge funds and large institutions have $3.71B invested in Avidity Biosciences in 2024 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 85 increasing their positions, 79 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
4% less funds holding
Funds holding: 245 → 236 (-9)
20% less funds holding in top 10
Funds holding in top 10: 10 → 8 (-2)
36% less capital invested
Capital invested by funds: $5.8B → $3.71B (-$2.09B)
Holders
236
Holding in Top 10
8
Calls
$19.5M
Puts
$20.9M
Top Buyers
| 1 | +$90.1M | |
| 2 | +$44.9M | |
| 3 | +$26.1M | |
| 4 |
Morgan Stanley
New York
|
+$25.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$17.2M |
Top Sellers
| 1 | -$48.7M | |
| 2 | -$29.5M | |
| 3 | -$24.8M | |
| 4 |
D.E. Shaw & Co
New York
|
-$23M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$21.8M |